Sleep Aids Review

Transcept Pharmaceuticals, Inc. announced today an update on its plans to seek U.S. Food and Drug Administration approval of Intermezzo® for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.  Transcept met with the FDA on January 20, 2010 to discuss the Complete Response Letter dated October 28, 2009, and received the ...